Enlivex Therapeutics Ltd. Cash Conversion Cycle 2011-2026 | ENLV

Annual Cash Conversion Cycle Enlivex Therapeutics Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-193	-106	-18.4	-368	-1.03 K	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
-18.4	-1.03 K	-344

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Aquestive Therapeutics AQST	-172	$ 4.12	-0.36 %	$ 441 M	USA
Arcturus Therapeutics Holdings ARCT	21.2	$ 8.32	3.67 %	$ 228 M	Israel
Arcutis Biotherapeutics ARQT	158	$ 23.65	0.08 %	$ 3.01 B	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
BioXcel Therapeutics BTAI	-32.5 K	$ 1.16	-2.12 %	$ 14.2 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	-1.92	-	1.93 %	$ 17.4 M	USA
Catalyst Biosciences CBIO	71.5	$ 19.48	0.39 %	$ 1.74 B	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Codexis CDXS	-15.2	$ 1.95	6.87 %	$ 170 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Cerus Corporation CERS	47	$ 1.91	2.69 %	$ 364 M	USA
Coherus BioSciences CHRS	149	$ 1.72	-0.87 %	$ 201 M	USA
CollPlant Biotechnologies Ltd. CLGN	130	$ 0.46	-13.02 %	$ 5.27 M	Israel
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
AstraZeneca PLC AZN	-58	-	-	$ 96.9 B	Britain
Catalyst Pharmaceuticals CPRX	120	$ 24.95	1.05 %	$ 3.05 B	USA
Celldex Therapeutics CLDX	-3.74 K	$ 31.33	0.85 %	$ 2.08 B	USA
Cardiff Oncology CRDF	294	$ 1.6	1.27 %	$ 107 M	USA